The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Yike Gao, Fei Yao, Junyi Pang, Tianlin Sun, Changbin Zhu, Shafei Wu, Zhiyong Liang. Differential FGFR1 copy number status displays unique tumour immune microenvironment in triple‐negative breast cancer, The Journal of Pathology. 2026; path.70121. https://doi.org/10.1002/path.70121 |
|
2 |
2025 |
Yilin Ma, Mengqin Guo, Yang Liu, Zhengwei Huang. Conceptualization of fibroblast growth factor receptor 1 targeting nanomedicines, Exploration of Targeted Anti-tumor Therapy. 2025; 6: 1002353. https://doi.org/10.37349/etat.2025.1002353 |
|
3 |
2026 |
Yang Zhong, Xin Jiang, Fei Wang, Jianbin Xiao, Qiang Feng, Guixian Ye, Zefeng Gao, Jianmin Wang, Jingfeng Liu. HERV2365 upregulates FGF1 expression by sponging miR-326 to promote the progression of intrahepatic cholangiocarcinoma, iScience. 2026; 29: 115852115852. https://doi.org/10.1016/j.isci.2026.115852 |
|
4 |
2026 |
Diala Haykal, Michael Gold, Edward Lain, Jeremy Green, Patricia K. Farris. Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity, Journal of Cosmetic Dermatology. 2026; 25: e70788. https://doi.org/10.1111/jocd.70788 |